IBDEI11R ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18459,0)
 ;;=284.89^^102^1185^3
 ;;^UTILITY(U,$J,358.3,18459,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18459,1,4,0)
 ;;=4^APLASTIC ANEMIA,OTH SPEC
 ;;^UTILITY(U,$J,358.3,18459,1,5,0)
 ;;=5^284.89
 ;;^UTILITY(U,$J,358.3,18459,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,18460,0)
 ;;=284.01^^102^1185^5
 ;;^UTILITY(U,$J,358.3,18460,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18460,1,4,0)
 ;;=4^CONSTITUTION RBC APLASIA
 ;;^UTILITY(U,$J,358.3,18460,1,5,0)
 ;;=5^284.01
 ;;^UTILITY(U,$J,358.3,18460,2)
 ;;=^334035
 ;;^UTILITY(U,$J,358.3,18461,0)
 ;;=284.09^^102^1185^4
 ;;^UTILITY(U,$J,358.3,18461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18461,1,4,0)
 ;;=4^CONST APLASTC ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,18461,1,5,0)
 ;;=5^284.09
 ;;^UTILITY(U,$J,358.3,18461,2)
 ;;=^334036
 ;;^UTILITY(U,$J,358.3,18462,0)
 ;;=284.12^^102^1185^7
 ;;^UTILITY(U,$J,358.3,18462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18462,1,4,0)
 ;;=4^DRUG-INDUCED PANCYTOPENIA
 ;;^UTILITY(U,$J,358.3,18462,1,5,0)
 ;;=5^284.12
 ;;^UTILITY(U,$J,358.3,18462,2)
 ;;=^340500
 ;;^UTILITY(U,$J,358.3,18463,0)
 ;;=284.2^^102^1185^8
 ;;^UTILITY(U,$J,358.3,18463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18463,1,4,0)
 ;;=4^MYELOPHTHISIS
 ;;^UTILITY(U,$J,358.3,18463,1,5,0)
 ;;=5^284.2
 ;;^UTILITY(U,$J,358.3,18463,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,18464,0)
 ;;=284.19^^102^1185^9
 ;;^UTILITY(U,$J,358.3,18464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18464,1,4,0)
 ;;=4^PANCYTOPENIA
 ;;^UTILITY(U,$J,358.3,18464,1,5,0)
 ;;=5^284.19
 ;;^UTILITY(U,$J,358.3,18464,2)
 ;;=^340501
 ;;^UTILITY(U,$J,358.3,18465,0)
 ;;=284.81^^102^1185^10
 ;;^UTILITY(U,$J,358.3,18465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18465,1,4,0)
 ;;=4^RED CELL APLASIA
 ;;^UTILITY(U,$J,358.3,18465,1,5,0)
 ;;=5^284.81
 ;;^UTILITY(U,$J,358.3,18465,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,18466,0)
 ;;=281.9^^102^1185^6
 ;;^UTILITY(U,$J,358.3,18466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18466,1,4,0)
 ;;=4^DEFICIENCY ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,18466,1,5,0)
 ;;=5^281.9
 ;;^UTILITY(U,$J,358.3,18466,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,18467,0)
 ;;=V59.8^^102^1186^1
 ;;^UTILITY(U,$J,358.3,18467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18467,1,4,0)
 ;;=4^ORG OR TISSUE DONOR NEC
 ;;^UTILITY(U,$J,358.3,18467,1,5,0)
 ;;=5^V59.8
 ;;^UTILITY(U,$J,358.3,18467,2)
 ;;=^295538
 ;;^UTILITY(U,$J,358.3,18468,0)
 ;;=042.^^102^1187^1
 ;;^UTILITY(U,$J,358.3,18468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18468,1,4,0)
 ;;=4^HIV DISEASE
 ;;^UTILITY(U,$J,358.3,18468,1,5,0)
 ;;=5^042.
 ;;^UTILITY(U,$J,358.3,18468,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,18469,0)
 ;;=403.11^^102^1188^1
 ;;^UTILITY(U,$J,358.3,18469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18469,1,4,0)
 ;;=4^BEN HYP KIDNEY W CHR KID
 ;;^UTILITY(U,$J,358.3,18469,1,5,0)
 ;;=5^403.11
 ;;^UTILITY(U,$J,358.3,18469,2)
 ;;=^334241
 ;;^UTILITY(U,$J,358.3,18470,0)
 ;;=250.43^^102^1188^4
 ;;^UTILITY(U,$J,358.3,18470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18470,1,4,0)
 ;;=4^DM I RENAL UNCNTRLD
 ;;^UTILITY(U,$J,358.3,18470,1,5,0)
 ;;=5^250.43
 ;;^UTILITY(U,$J,358.3,18470,2)
 ;;=^331798
 ;;^UTILITY(U,$J,358.3,18471,0)
 ;;=250.41^^102^1188^3
 ;;^UTILITY(U,$J,358.3,18471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18471,1,4,0)
 ;;=4^DM I RENAL
 ;;^UTILITY(U,$J,358.3,18471,1,5,0)
 ;;=5^250.41
 ;;^UTILITY(U,$J,358.3,18471,2)
 ;;=^331796
 ;;^UTILITY(U,$J,358.3,18472,0)
 ;;=250.42^^102^1188^6
 ;;^UTILITY(U,$J,358.3,18472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18472,1,4,0)
 ;;=4^DM II RENAL UNCNTRLD
 ;;^UTILITY(U,$J,358.3,18472,1,5,0)
 ;;=5^250.42
 ;;
 ;;$END ROU IBDEI11R
